Switch to:
More From Other Websites
3 Key Therapeutic Segments Drive Branded Revenues Apr 01 2015
Analyzing Pfizer’s Research and Development Apr 01 2015
Dyax Soars As Rare-Disease Drug Wows Wall Street Apr 01 2015
Pfizer’s Global Established Pharmaceutical Segment Apr 01 2015
Teva Announces FDA Approval of ProAir® RespiClick Apr 01 2015
8:01 am Teva Pharma announces the FDA has approved ProAir RespiClick Apr 01 2015
Teva Announces FDA Approval of ProAir® RespiClick Apr 01 2015
Canaccord Hot And Cold On Deals By Teva Pharmaceutical, ImmunoGen Mar 31 2015
Teva Reinforces Leadership Position in CNS with Acquisition of Auspex Mar 31 2015
5 Stocks, 5 trades: CHTR, DHI, IBM, TEVA, & CBG Mar 31 2015
Analyst Sees No Rival Bids For Auspex Pharmaceuticals Mar 31 2015
Hedge fund Tigershark Partners to close doors Mar 31 2015
Oppenheimer: Teva Is Now Worth $77/Share, More Deals To Come Mar 31 2015
Healthcare ETFs Rally on Monday Merger Mania - ETF News And Commentary Mar 31 2015
Teva Expands Hypertension Line with Launch of Generic Exforge® Tablets in the United States Mar 31 2015
Teva Expands Hypertension Line with Launch of Generic Exforge® Tablets in the United States Mar 31 2015
Analysts' Actions -- IAC/InterActiveCorp, Priceline, Reliance Steel, Teva and More Mar 31 2015
Early movers: MRH, JCI, DHI, PHG, TEVA, CVC & more Mar 31 2015
Teva Pharma upgraded by Oppenheimer Mar 31 2015
Five Firms Take Lead in Health-Care Deal Flurry: Business of Law Mar 30 2015
Stocks: Dow up 264, back in the black for '15 Mar 30 2015
Asian Futures Jump Amid Global Rally; Crude, Gold Decline Mar 30 2015
Teva, Horizon See Growth In Orphan-Drug Takeovers Mar 30 2015
Stocks End Higher on China Easing Hopes, M&A Activity Mar 30 2015
​Teva Pharmaceutical to buy drug maker Auspex Mar 30 2015
US STOCKS-Wall St rebounds from recent losses; deals help Mar 30 2015
Norcraft and Auspex are big market movers Mar 30 2015
Teva buying Auspex for $3.2 billion Mar 30 2015
Teva to buy U.S. drug developer Auspex Pharma for $3.5 bln Mar 30 2015
US STOCKS-Wall St higher as biotechs rally on M&A deals Mar 30 2015
Teva Reinforces Leadership Position in CNS with Acquisition of Auspex Mar 30 2015
Teva Announces Pricing of €2 Billion of Senior Notes Mar 24 2015
Teva Announces New Head of Business Development, Strategy and Innovation Mar 23 2015
Teva’s TEV-48125 Meets Primary and Secondary Endpoints in Episodic Migraine Study, Demonstrating... Mar 23 2015
Teva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from Teva Mar 17 2015
Teva x JammyPack Remind Us Why We Love Spring Break Mar 03 2015
Teva Announces Sale of Sellersville, PA Facility Mar 02 2015
Teva Announces Early Results of Debt Tender Offer, Pricing, Election of Early Settlement and... Feb 27 2015
Teva to Present at the Cowen & Company 35th Annual Healthcare Conference Feb 26 2015
Teva Announces FDA Acceptance for Review of NDA for its Investigational Twice-Daily Hydrocodone... Feb 25 2015
Teva Announces Positive Results for TEV-48125 in Phase IIb Chronic Migraine Study Meeting Primary... Feb 24 2015
The Lancet Respiratory Medicine and AAAAI Publish Positive Data from Phase III Trials of Teva’s... Feb 23 2015
Teva to Present New Respiratory Data at 2015 Annual Meeting of the American Academy of Allergy,... Feb 20 2015
Teva Bolsters Injectable Portfolio with Launch of Generic Lovenox® and Generic Zyvox® in the... Feb 17 2015
Teva and Eagle Pharmaceuticals Announce Teva’s License to Commercialize Eagle’s Bendamustine... Feb 17 2015
Eagle Pharmaceuticals to Hold Conference Call at 8:30 a.m. EST Today to Discuss Licensing Agreement... Feb 17 2015
Teva and Eagle Pharmaceuticals Announce Teva’s License to Commercialize Eagle’s Bendamustine... Feb 17 2015
U.S. Supreme Court rules for Teva over MS drug patent Jan 20 2015
U.S. Supreme Court rules for Teva over MS drug patent Jan 20 2015
Supreme Court sides with Teva in drug dispute Jan 20 2015
Teva Pharm sees 2015 revenue lower than forecast Dec 11 2014
Merck committed to Cubist after patent losses Dec 09 2014
Supreme Court weighs generic drug dispute Oct 15 2014
FTC sues AbbVie, Teva over generic AndroGel Sep 08 2014
UK court backs Teva rival to AstraZeneca lung drug Sep 03 2014
UK court backs Teva rival to AstraZeneca lung drug Sep 03 2014
Russian OTC drugs market may be shut off to European vendors as escalating Russia-Ukraine tensions... Aug 31 2014
Teva to name new chairman - activist investor Landa says Jul 14 2014
Pharmaceutical giant Teva's chairman to resign Jun 18 2014
Teva Pharm's chairman Phillip Frost to step down by year end Jun 18 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK